Clinical utility of common serum rheumatologic tests.

Serum rheumatologic tests are generally most useful for confirming a clinically suspected diagnosis. Testing for rheumatoid factor is appropriate when rheumatoid arthritis, Sjögren's syndrome or cryoglobulinemia is suspected. Antinuclear antibody testing is highly sensitive for systemic lupus erythematosus and drug-induced lupus. Anti-double-stranded DNA antibodies correlate with lupus nephritis; the titer often corresponds with disease activity in systemic lupus erythematosus. Testing for anti-Ro (anti-SS-A) or anti-La (anti-SS-B) may help confirm the diagnosis of Sjögren's syndrome or systemic lupus erythematosus; these antibodies are associated with the extraglandular manifestations of Sjögren's syndrome. Cytoplasmic antineutrophil cytoplasmic antibody testing is highly sensitive and specific for Wegener's granulomatosis. Human leukocyte antigen-B27 is frequently present in ankylosing spondylitis and Reiter's syndrome, but the background presence of this antibody in white populations limits the value of testing. An elevated erythrocyte sedimentation rate (ESR) is a diagnostic criterion for polymyalgia rheumatica and temporal arteritis; however, specificity is quite low. ESR values tend to correlate with disease activity in rheumatoid arthritis and may be useful for monitoring therapeutic response.

[1]  B. Le,et al.  Normal erythrocyte sedimentation rate and age. , 1967 .

[2]  F. Wolfe,et al.  The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients. , 1991, Arthritis and rheumatism.

[3]  L. Böttiger,et al.  Normal erythrocyte sedimentation rate and age. , 1967, British medical journal.

[4]  N. Talal,et al.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. , 1972, Clinical and experimental immunology.

[5]  M. Suarez‐Almazor,et al.  Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. , 1998, The Journal of rheumatology.

[6]  T. Delbanco,et al.  The rheumatoid factor: an analysis of clinical utility. , 1991, The American journal of medicine.

[7]  M. Satoh,et al.  Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. , 1994, Rheumatic diseases clinics of North America.

[8]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[9]  M. Brigden Clinical utility of the erythrocyte sedimentation rate. , 1999, American family physician.

[10]  N. Brot,et al.  Antiribosomal antibodies in systemic lupus erythematosus. , 1992, Rheumatic diseases clinics of North America.

[11]  F. Wolfe,et al.  The clinical and research significance of the erythrocyte sedimentation rate. , 1994, The Journal of rheumatology.

[12]  V. Rodríguez-Valverde,et al.  Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. , 1997, Archives of internal medicine.

[13]  R. Shmerling Rheumatic disease: choosing the most useful diagnostic tests. , 1996, Geriatrics.

[14]  F. Arnett Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[15]  M. Liang,et al.  The erythrocyte sedimentation rate. Guidelines for rational use. , 1986, Annals of internal medicine.

[16]  P. Fauchald,et al.  Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. , 1972, Annals of internal medicine.

[17]  E. Clair Anti-La antibodies. , 1992 .

[18]  G. Hoffman,et al.  Antineutrophil cytoplasmic antibodies. , 1998, Arthritis and rheumatism.

[19]  S. Bedell,et al.  Erythrocyte sedimentation rate. From folklore to facts. , 1985, The American journal of medicine.

[20]  R. Cebul,et al.  Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. , 1986, Pediatrics.

[21]  J. Harley,et al.  Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus. , 1992, Rheumatic diseases clinics of North America.

[22]  E. Hay,et al.  Clinical course of patients with anti-RNP antibodies. , 1993, Journal of Rheumatology.

[23]  D. Estes,et al.  Antinuclear antibodies. , 1972, Pathobiology annual.